Nanoparticles for skin penetration enhancement--a comparison of a dendritic core-multishell-nanotransporter and solid lipid nanoparticles.

Nanosized particles are of growing interest for topical treatment of skin diseases to increase skin penetration of drugs and to reduce side effects. Effects of the particle structure and size were studied loading nile red to dendritic core-multishell (CMS) nanotransporters (20-30 nm) and solid lipid nanoparticles (SLNs, 150-170 nm). Interaction properties of CMS nanotransporters with the dye molecules--attachment to the carrier surface or incorporation in the carrier matrix--were studied by UV/Vis and parelectric spectroscopy. Pig skin penetration was studied ex vivo using a cream for reference. Interactions of SLN and skin were followed by scanning electron microscopy, internalisation of the particles by viable keratinocytes by laser scanning microscopy. Incorporating nile red into a stable dendritic nanoparticle matrix, dye amounts increased eightfold in the stratum corneum and 13-fold in the epidermis compared to the cream. Despite SLN degradation at the stratum corneum surface, SLN enhanced skin penetration less efficiently (3.8- and 6.3-fold). Viable human keratinocytes showed an internalisation of both nanocarriers. In conclusion, CMS nanotransporters can favour the penetration of a model dye into the skin even more than SLN which may reflect size effects.

[1]  R. Müller,et al.  Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. , 2002, Advanced drug delivery reviews.

[2]  M Simeonova,et al.  Nanoparticles as drug carrier system of 5-fluorouracil in local treatment of patients with superficial basal cell carcinoma. , 2005, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[3]  R. Bittl,et al.  Interaction of drug molecules with carrier systems as studied by parelectric spectroscopy and electron spin resonance. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[4]  R. Mülhaupt,et al.  Controlled Synthesis of Hyperbranched Polyglycerols by Ring-Opening Multibranching Polymerization , 1999 .

[5]  P. Weigel,et al.  Recycling of the asialoglycoprotein receptor in isolated rat hepatocytes. ATP depletion blocks receptor recycling but not a single round of endocytosis. , 1985, The Journal of biological chemistry.

[6]  Structure and dynamics of drug-carrier systems as studied by parelectric spectroscopy. , 2007, Advanced drug delivery reviews.

[7]  F. Bonte,et al.  Cutaneous bioavailability in hairless rats of tretinoin in liposomes or gel. , 1993, Journal of pharmaceutical sciences.

[8]  B. Röder,et al.  Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[9]  R H Guy,et al.  Skin penetration and distribution of polymeric nanoparticles. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[10]  H. Höltje,et al.  Glucocorticoids for Human Skin: New Aspects of the Mechanism of Action , 2005, Skin Pharmacology and Physiology.

[11]  H. Maibach,et al.  Liposomes and Niosomes as Topical Drug Delivery Systems , 2005, Skin Pharmacology and Physiology.

[12]  H. Korting,et al.  Lipid nanoparticles for improved topical application of drugs for skin diseases. , 2007, Advanced drug delivery reviews.

[13]  M. Schoenfisch,et al.  Cytotoxicity of polypropylenimine dendrimer conjugates on cultured endothelial cells. , 2007, Biomacromolecules.

[14]  C. Zouboulis,et al.  Cyproterone Acetate Loading to Lipid Nanoparticles for Topical Acne Treatment: Particle Characterisation and Skin Uptake , 2007, Pharmaceutical Research.

[15]  M. Schaller,et al.  Drug Targeting by Solid Lipid Nanoparticles for Dermal Use , 2002, Journal of drug targeting.

[16]  Claus-Michael Lehr,et al.  The Use of Reconstructed Human Epidermis for Skin Absorption Testing: Results of the Validation Study , 2008, Alternatives to laboratory animals : ATLA.

[17]  K. Landfester,et al.  Uptake of functionalized, fluorescent-labeled polymeric particles in different cell lines and stem cells. , 2006, Biomaterials.

[18]  Nissim Garti,et al.  Microemulsions as transdermal drug delivery vehicles. , 2006, Advances in colloid and interface science.

[19]  Michał R. Radowski,et al.  Supramolecular aggregates of dendritic multishell architectures as universal nanocarriers. , 2007, Angewandte Chemie.

[20]  J. Lademann,et al.  Penetration profile of microspheres in follicular targeting of terminal hair follicles. , 2004, The Journal of investigative dermatology.

[21]  Michael S Roberts,et al.  Molecular size as the main determinant of solute maximum flux across the skin. , 2004, The Journal of investigative dermatology.

[22]  S. Fowler,et al.  Spectrofluorometric studies of the lipid probe, nile red. , 1985, Journal of lipid research.

[23]  E. Waigmann,et al.  Detection of nanometer-sized particles in living cells using modern fluorescence fluctuation methods. , 2005, Biochemical and biophysical research communications.

[24]  P. Couvreur,et al.  Biological characterization of folic acid-conjugated poly(H2NPEGCA-co-HDCA) nanoparticles in cellular models , 2007, Journal of drug targeting.

[25]  M. Fantini,et al.  Reverse Hexagonal Phase Nanodispersion of Monoolein and Oleic Acid for Topical Delivery of Peptides: in Vitro and in Vivo Skin Penetration of Cyclosporin A , 2006, Pharmaceutical Research.

[26]  J. Ring,et al.  Improved risk–benefit ratio for topical triamcinolone acetonide in Transfersome® in comparison with equipotent cream and ointment: a randomized controlled trial , 2003, The British journal of dermatology.

[27]  S. Wartewig,et al.  Solid Lipid Nanoparticles (SLN) and Oil-Loaded SLN Studied by Spectrofluorometry and Raman Spectroscopy , 2005, Pharmaceutical Research.

[28]  M. Schäfer-Korting,et al.  Liposomal tretinoin for uncomplicated acne vulgaris , 1994, The clinical investigator.

[29]  J. M. Marchetti,et al.  Stratum corneum lipids liposomes for the topical delivery of 5-aminolevulinic acid in photodynamic therapy of skin cancer: preparation and in vitro permeation study , 2001, BMC dermatology.

[30]  Geoffrey Lee Prediction of Percutaneous Penetration , 1997 .

[31]  R. Haag,et al.  Supramolecular drug-delivery systems based on polymeric core-shell architectures. , 2004, Angewandte Chemie.

[32]  J A Bouwstra,et al.  Skin structure and mode of action of vesicles. , 2002, Advanced drug delivery reviews.

[33]  Hatem Fessi,et al.  Enhancement of Topical Delivery from Biodegradable Nanoparticles , 2004, Pharmaceutical Research.

[34]  S. Nacht,et al.  The Microsponge Delivery System (MDS): a topical delivery system with reduced irritancy incorporating multiple triggering mechanisms for the release of actives. , 1996, Journal of microencapsulation.

[35]  Michael A Repka,et al.  Characterization of hot-melt extruded drug delivery systems for onychomycosis. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[36]  M. Schaller,et al.  Direct evidence for uptake of intact liposomes encapsulating silver sulfadiazine by cultured human keratinocytes based on combined transmission electron microscopy and X-ray microanalysis , 1997, Antimicrobial agents and chemotherapy.

[37]  M Schaller,et al.  Interaction of cultured human keratinocytes with liposomes encapsulating silver sulphadiazine: proof of the uptake of intact vesicles , 1996, The British journal of dermatology.

[38]  H. Hamm,et al.  Dendritic molecular transporters provide control of delivery to intracellular compartments. , 2007, Bioconjugate chemistry.

[39]  Claus-Michael Lehr,et al.  Reconstructed Human Epidermis for Skin Absorption Testing: Results of the German Prevalidation Study , 2006, Alternatives to laboratory animals : ATLA.

[40]  Kumar A. Shah,et al.  Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery. , 2007, International journal of pharmaceutics.

[41]  S. Wissing,et al.  The influence of the crystallinity of lipid nanoparticles on their occlusive properties. , 2002, International journal of pharmaceutics.

[42]  G. Cevc Lipid vesicles and other colloids as drug carriers on the skin. , 2004, Advanced drug delivery reviews.

[43]  C. Bocca,et al.  Cellular uptake and cytotoxicity of solid lipid nanospheres (SLN) incorporating doxorubicin or paclitaxel. , 2000, International journal of pharmaceutics.

[44]  G. Ogden,et al.  A technique for the study of endocytosis in human oral epithelial cells. , 1999, Archives of oral biology.

[45]  H. Korting,et al.  Prednicarbate Biotransformation in Human Foreskin Keratinocytes and Fibroblasts , 1997, Pharmaceutical Research.

[46]  H. Korting,et al.  Glucocorticoid entrapment into lipid carriers--characterisation by parelectric spectroscopy and influence on dermal uptake. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[47]  H. Maibach,et al.  Controlled release of benzoyl peroxide from a porous microsphere polymeric system can reduce topical irritancy. , 1991, Journal of the American Academy of Dermatology.